A determined mother in Scotland is advocating for cannabis-based medication to help her two-year-old daughter, Minnie Granger, who suffers from severe seizures. Minnie, from Cardonald, was experiencing more than 100 seizures each day before being prescribed cannabidiol (CBD). Minnie’s mother, Hannah Granger, has observed a reduction in smaller seizures but is seeking medication containing THC, the psychoactive element in cannabis, to further improve Minnie’s quality of life.
Hannah, aged 31, believes that THC-containing medication could potentially reduce the frequency of Minnie’s severe seizures, which can cause her to stop breathing for nearly a minute. While medicinal cannabis was legalized in the UK in 2018, the National Health Service (NHS) maintains that the risks associated with THC-containing medications are not yet clear, emphasizing the need for further clinical trials.
Minnie was diagnosed with a rare condition at just eight weeks old, characterised by the absence of 21 genes, some linked to epilepsy. She endures six different types of seizures and requires round-the-clock care. Despite trying nine different anti-seizure medications, doctors have indicated that Minnie may be resistant to treatment, offering little hope for seizure management.
Hannah faces challenges in obtaining a prescription for medication with higher THC content, which she believes could significantly benefit Minnie. She highlights the urgency of Minnie’s situation, expressing concern that delays in accessing necessary medications could jeopardize her daughter’s life. Hannah has witnessed positive transformations in other children using THC-infused cannabis oil and is determined to provide the best care for Minnie.
The NHS cautions about the unclear risks associated with THC-containing medicines, citing potential issues such as psychosis and dependency. However, Hannah remains steadfast in her belief that the benefits for Minnie outweigh the potential risks. She urges for expedited access to cannabis-based medication for Minnie, emphasising the need for timely intervention to improve her daughter’s quality of life.
Hannah is further supported by a UK group, End Our Pain, which advocates for the legalisation of cannabis-based drugs for children. She acknowledges the forthcoming national trials on cannabis-derived medications but stresses the immediate need for Minnie to receive appropriate treatment. Hannah’s unwavering determination and advocacy for her daughter’s health exemplify a mother’s love and dedication in the face of adversity.